These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18794514)

  • 1. Three cases of successful tryptophan add-on or monotherapy of hepatitis C and IFNalpha-associated mood disorders.
    Schaefer M; Winterer J; Sarkar R; Uebelhack R; Franke L; Heinz A; Friebe A
    Psychosomatics; 2008; 49(5):442-6. PubMed ID: 18794514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatment strategies for depression in patients with hepatitis C.
    Loftis JM; Turner EH
    Psychosomatics; 2010; 51(4):357-8. PubMed ID: 20587769
    [No Abstract]   [Full Text] [Related]  

  • 3. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
    Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-induced depression in chronic hepatitis C.
    Horsmans Y
    J Antimicrob Chemother; 2006 Oct; 58(4):711-3. PubMed ID: 16951413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
    Beratis S; Katrivanou A; Georgiou S; Monastirli A; Pasmatzi E; Gourzis P; Tsambaos D
    J Psychosom Res; 2005 Jan; 58(1):15-8. PubMed ID: 15771865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
    Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
    Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.
    Wichers MC; Kenis G; Leue C; Koek G; Robaeys G; Maes M
    Biol Psychiatry; 2006 Jul; 60(1):77-9. PubMed ID: 16487941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.
    Hauser P; Khosla J; Aurora H; Laurin J; Kling MA; Hill J; Gulati M; Thornton AJ; Schultz RL; Valentine AD; Meyers CA; Howell CD
    Mol Psychiatry; 2002; 7(9):942-7. PubMed ID: 12399946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of chronic hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 2000; 150(23-24):481-5. PubMed ID: 11205179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.